In line with these experimental observations, analysis of primary and metastatic melanoma patient samples identified upregulation of MCT1 and MCT4 proteins as melanoma cells transition from the primary tumour to metastases [32,33], and MCT1 and MCT4 expression is associated with poor prognostic variables and shorter overall survival [33]. This evidence concerns the gene SLC16A1 and melanoma.